VRDN · CIK 1590750
What Viridian Therapeutics, Inc. told the SEC could break it.
1 self-disclosed vulnerability, pulled from its own filings — each in the company’s words, with the source. This is the risk register almost nobody reads.
A limited set so far — we surface every cited disclosure we’ve extracted for VRDN. More may follow as additional filings are processed.
In its own words
What could break it.
Regulatory & policy
- Proposed U.S. tariff on imported / foreign-manufactured drug products — bites given China (WuXi) manufacturingmedium
Viridian manufactures all clinical drug substance and drug product abroad through a single Chinese CDMO (WuXi Biologics, Hong Kong), so a proposed U.S. tariff on drug products imported from abroad — or made using foreign-imported materials — would directly raise its cost of goods and erode returns on any approved product. The filing notes the tariff's implementation timeline is not yet finalized, adding uncertainty. The exposure compounds the single-source/China-CDMO concentration captured in the WuXi supply edge (BIOSECURE-style policy risk also looms over China CDMOs).
“our ability to realize an adequate return on the sale of drug products (if approved) that are imported from abroad or manufactured using products or materials imported from abroad. The timeline for implementation of this tariff has not yet been finalized.”
The hidden graph
Who it depends on, and who depends on it.
Relationships surfaced from filings — including ones disclosed by the other side, which is how the non-obvious ones come to light.
Its customers
Kissei Pharmaceutical Co., Ltd.
“Kissei will be responsible for developing and seeking regulatory approval of the licensed products in Japan, subject to oversight from a joint steering committee.”
Cited →
Its suppliers
WuXi Biologics (Hong Kong) Limited
“We currently rely on a single multi-site CDMO for manufacturing our clinical materials, WuXi Biologics (Hong Kong) Limited (“WuXi”), although other avenues remain available if our current manufacturer were to be negatively impacted.”
Cited →
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch